MedPath

Dextrose Prolotherapy Injection in the Plantar Fasciitis

Not Applicable
Recruiting
Conditions
Plantar fascial fibromatosis
M72.2
Plantar fascial fibromatosis.
Registration Number
IRCT20140306016865N2
Lead Sponsor
Bagheiat-allah University of Medical Sciences
Brief Summary

Not available

Detailed Description

Not available

Recruitment & Eligibility

Status
Recruiting
Sex
All
Target Recruitment
78
Inclusion Criteria

Age between 20 to 50 years
A typical history of plantar fascistic and localized tenderness in the medial side of the heel
providing informed consent for participation in the study.

Exclusion Criteria

Not provided

Study & Design

Study Type
interventional
Study Design
Not specified
Primary Outcome Measures
NameTimeMethod
Pain intensity at the standing position. Timepoint: All the outcomes were evaluated at the baseline visit and at 1 week, 1 month, and 3 months after the intervention. Method of measurement: Visual analog scale.
Secondary Outcome Measures
NameTimeMethod
Early morning pain; pain on joint movement; daily activities; climbing stairs and exercise tolerance. Timepoint: All the outcomes were evaluated at the baseline visit and at 1 week, 1 month, and 3 months after the intervention. Method of measurement: Visual analog scale. We also assess the ability to perform daily activities, climbing stairs and exercise tolerance with FAAM Questionnaire.
© Copyright 2025. All Rights Reserved by MedPath